JPY 4370.0
(1.51%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 222.34 Billion JPY | 2.35% |
2022 | 217.24 Billion JPY | 5.9% |
2021 | 205.13 Billion JPY | 2.53% |
2020 | 200.07 Billion JPY | -0.19% |
2019 | 200.46 Billion JPY | 2.08% |
2018 | 196.36 Billion JPY | -4.3% |
2017 | 205.19 Billion JPY | 5.53% |
2016 | 194.44 Billion JPY | -1.25% |
2015 | 196.9 Billion JPY | 12.69% |
2014 | 174.73 Billion JPY | -9.35% |
2013 | 192.76 Billion JPY | 8.85% |
2012 | 177.09 Billion JPY | -2.45% |
2011 | 181.54 Billion JPY | -5.34% |
2010 | 191.79 Billion JPY | 5.63% |
2009 | 181.57 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 217.45 Billion JPY | -2.2% |
2024 Q2 | 224.61 Billion JPY | 3.29% |
2023 FY | 222.34 Billion JPY | 2.35% |
2023 Q4 | 222.34 Billion JPY | -4.45% |
2023 Q1 | 214.23 Billion JPY | -1.38% |
2023 Q3 | 232.7 Billion JPY | 3.25% |
2023 Q2 | 225.37 Billion JPY | 5.2% |
2022 Q3 | 230.75 Billion JPY | 5.93% |
2022 Q2 | 217.83 Billion JPY | 9.58% |
2022 FY | 217.24 Billion JPY | 5.9% |
2022 Q1 | 198.78 Billion JPY | -3.1% |
2022 Q4 | 217.24 Billion JPY | -5.86% |
2021 Q3 | 214.4 Billion JPY | 2.97% |
2021 Q2 | 208.22 Billion JPY | 5.61% |
2021 FY | 205.13 Billion JPY | 2.53% |
2021 Q4 | 205.13 Billion JPY | -4.32% |
2021 Q1 | 197.16 Billion JPY | -1.46% |
2020 Q2 | 204.75 Billion JPY | 1.64% |
2020 Q1 | 201.44 Billion JPY | 0.49% |
2020 Q3 | 212.08 Billion JPY | 3.58% |
2020 Q4 | 200.07 Billion JPY | -5.66% |
2020 FY | 200.07 Billion JPY | -0.19% |
2019 Q4 | 200.46 Billion JPY | -9.36% |
2019 Q1 | 212.33 Billion JPY | 8.13% |
2019 FY | 200.46 Billion JPY | 2.08% |
2019 Q2 | 220.31 Billion JPY | 3.76% |
2019 Q3 | 221.16 Billion JPY | 0.38% |
2018 Q1 | 219.76 Billion JPY | 7.1% |
2018 Q4 | 196.36 Billion JPY | -12.79% |
2018 Q3 | 225.17 Billion JPY | 5.02% |
2018 Q2 | 214.41 Billion JPY | -2.44% |
2018 FY | 196.36 Billion JPY | -4.3% |
2017 Q1 | 211.25 Billion JPY | 8.65% |
2017 Q4 | 205.19 Billion JPY | -9.54% |
2017 Q3 | 226.84 Billion JPY | 4.21% |
2017 Q2 | 217.67 Billion JPY | 3.04% |
2017 FY | 205.19 Billion JPY | 5.53% |
2016 Q2 | 220.83 Billion JPY | 5.45% |
2016 Q3 | 215.9 Billion JPY | -2.23% |
2016 Q1 | 209.42 Billion JPY | 6.36% |
2016 Q4 | 194.44 Billion JPY | -9.94% |
2016 FY | 194.44 Billion JPY | -1.25% |
2015 Q3 | 220.36 Billion JPY | 10.45% |
2015 FY | 196.9 Billion JPY | 12.69% |
2015 Q4 | 196.9 Billion JPY | -10.64% |
2015 Q2 | 199.51 Billion JPY | 9.5% |
2015 Q1 | 182.2 Billion JPY | 4.27% |
2014 Q3 | 190.92 Billion JPY | 4.86% |
2014 Q2 | 182.07 Billion JPY | -2.02% |
2014 Q1 | 185.82 Billion JPY | -3.6% |
2014 Q4 | 174.73 Billion JPY | -8.48% |
2014 FY | 174.73 Billion JPY | -9.35% |
2013 Q4 | 192.76 Billion JPY | -3.24% |
2013 Q1 | 186.11 Billion JPY | 5.09% |
2013 Q2 | 186.08 Billion JPY | -0.02% |
2013 Q3 | 199.21 Billion JPY | 7.06% |
2013 FY | 192.76 Billion JPY | 8.85% |
2012 Q2 | 183.31 Billion JPY | -2.83% |
2012 Q3 | 192.79 Billion JPY | 5.17% |
2012 Q4 | 177.09 Billion JPY | -8.14% |
2012 FY | 177.09 Billion JPY | -2.45% |
2012 Q1 | 188.65 Billion JPY | 3.91% |
2011 Q3 | 193.44 Billion JPY | 1.4% |
2011 Q2 | 190.76 Billion JPY | -0.31% |
2011 Q1 | 191.36 Billion JPY | -0.23% |
2011 FY | 181.54 Billion JPY | -5.34% |
2011 Q4 | 181.54 Billion JPY | -6.15% |
2010 Q2 | 196.89 Billion JPY | 2.97% |
2010 Q4 | 191.79 Billion JPY | -3.93% |
2010 Q1 | 191.21 Billion JPY | 5.31% |
2010 Q3 | 199.63 Billion JPY | 1.39% |
2010 FY | 191.79 Billion JPY | 5.63% |
2009 FY | 181.57 Billion JPY | 0.0% |
2009 Q4 | 181.57 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -13353.177% |
Euglena Co., Ltd. | 37.92 Billion JPY | -486.314% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | -3324.603% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | -1424.917% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | -940.586% |
Kao Corporation | 757.7 Billion JPY | 70.656% |
Niitaka Co., Ltd. | 9.35 Billion JPY | -2276.361% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | -124.28% |
Shiseido Company, Limited | 615.1 Billion JPY | 63.853% |
Lion Corporation | 188.22 Billion JPY | -18.125% |
Mandom Corporation | 20.05 Billion JPY | -1008.606% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -16657.788% |
Milbon Co., Ltd. | 7.45 Billion JPY | -2880.627% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | -1539.673% |
Fancl Corporation | 30.56 Billion JPY | -627.368% |
KOSÉ Corporation | 88.61 Billion JPY | -150.899% |
Cota Co., Ltd. | 3.85 Billion JPY | -5671.167% |
HABA Laboratories,Inc. | 3.92 Billion JPY | -5566.071% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -6961.061% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | -568.477% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | -824.845% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -20795.037% |
Almado, Inc. | 1.94 Billion JPY | -11323.378% |
I-ne CO., LTD. | 8.57 Billion JPY | -2492.003% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -4456.189% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -5625.19% |
AXXZIA Inc. | 2 Billion JPY | -10981.346% |
S.T. Corporation | 12.01 Billion JPY | -1751.153% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | -254.867% |
Earth Corporation | 60.4 Billion JPY | -268.085% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | -2751.192% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -13683.984% |
Ya-Man Ltd. | 3.97 Billion JPY | -5491.511% |
MTG Co., Ltd. | 11.73 Billion JPY | -1794.045% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -5229.289% |
SHOBIDO Corporation | 8.89 Billion JPY | -2398.993% |
Artnature Inc. | 23.42 Billion JPY | -849.084% |
Pigeon Corporation | 19.34 Billion JPY | -1049.114% |
Unicharm Corporation | 345.37 Billion JPY | 35.623% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | -679.764% |